Know Cancer

or
forgot password

Collection of Tissue, Blood and Other Specimens From Patients With Benign and Malignant Tumors of the Soft Tissue, Gastrointestinal Tract, and Other Intra-abdominal Sites.


N/A
18 Years
N/A
Open (Enrolling)
Both
Esophageal Cancer, Bile Duct Neoplasms, Gastric Cancer, Liver Cancer, Melanoma, Pancreatic Cancer, Sarcoma

Thank you

Trial Information

Collection of Tissue, Blood and Other Specimens From Patients With Benign and Malignant Tumors of the Soft Tissue, Gastrointestinal Tract, and Other Intra-abdominal Sites.


Inclusion Criteria:



For patients:

- All patients with benign or malignant tumors of the soft tissues, gastrointestinal
tract, and other intra-abdominal sites who will have or have had tissue, peritoneal,
pleural, cyst, urine, and/or other gastrointestinal fluid removed for therapeutic or
diagnostic purposes.

- Patients will be entered without preference for any particular racial/ethnic group.

- Patients may have received prior hormonal therapy, cytotoxic chemotherapy,
irradiation, immunotherapy or surgical therapy.

- Tissue and body fluid specimens must be a large enough quantity to allow routine
pathological analysis, with the research laboratory specimen removed from the
residual specimen which would otherwise be discarded.

Healthy Control Subjects:

- Any male or female with no concurrent malignancies (except for localized basal cell
or squamous cell skin cancer) within 5 years of enrollment.

- > or = to 18 years of age

- Any MSKCC employee will be allowed to participate as a healthy control, provided they
fulfill the above inclusion criteria and they enroll willfully and voluntarily

Exclusion Criteria:

Healthy Control Subjects:

- Attending physicians authorized to obtain informed consent may exercise discretion in
excluding individuals for appropriate medical or other (e.g. mentally impaired)
reasons.

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

To obtain & store tissues, blood, peritoneal, pleural, cyst & other gastrointestinal fluid from patients with benign or malignant tumors in order to carry out future laboratory studies on the causes, prevention, diagnosis & treatment of certain cancers.

Outcome Time Frame:

2 years

Safety Issue:

No

Principal Investigator

Peter Allen, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Institutional Review Board

Study ID:

00-032

NCT ID:

NCT00582647

Start Date:

March 2000

Completion Date:

December 2014

Related Keywords:

  • Esophageal Cancer
  • Bile Duct Neoplasms
  • Gastric Cancer
  • Liver Cancer
  • Melanoma
  • Pancreatic Cancer
  • Sarcoma
  • Bile Duct Neoplasms
  • Neoplasms
  • Esophageal Diseases
  • Esophageal Neoplasms
  • Liver Neoplasms
  • Stomach Neoplasms
  • Melanoma
  • Pancreatic Neoplasms
  • Soft Tissue Neoplasms
  • Sarcoma

Name

Location

Memorial Sloan-Kettering Cancer Center New York, New York  10021